Results 251 to 260 of about 141,166 (348)

Evaluating Pediatric Reference Ranges for Extended Immunophenotyping from a Finnish Cohort against Published References. [PDF]

J Clin Immunol
Äärimaa E, Kesäläinen A, Askeli S, Toivonen A, Savonius O, Brück O, Lusila P, Vettenranta K, Heinonen S, Jahnukainen T, Koskenvuo M, Siitonen S, Lehtimäki S, Kekäläinen E.   +13 more
europepmc   +1 more source

Paradoxically high rise in CD4 lymphocyte count in the immune reconstitution inflammatory syndrome in a patient with tuberculosis and HIV infection

V. S. Borovitsky, Frolova Op
openalex   +2 more sources

A Murine Bispecific Antibody Efficiently Redirects T Cells Against Calr Mutated Stem Cells In Vivo

American Journal of Hematology, EarlyView.
ABSTRACT Calreticulin (CALR) mutations are prevalent in 20%–30% of patients with BCR::ABL1‐negative myeloproliferative neoplasms (MPN). Mutant calreticulin (mutCALR), presented by the thrombopoietin receptor (MPL, also known as TPOR or CD110) on the surface of the disease‐initiating MPN progenitors, represents an ideal target for curative ...
Shengen Xiong, Tamara Wais, Cecilia Varga, Christina Schueller, Sarada Achyutuni, Robert Kralovics   +5 more
wiley   +1 more source

Higher soluble CD8 correlates with poor prognosis in hospitalized pulmonary infection patients. [PDF]

Ann Med
Li Y, Zhao N, Bai Y, An Y, Dai X, Liu H, Zhang H.   +6 more
europepmc   +1 more source

[Total lymphocyte-count as a substitute for CD4 positive lymphocyte determination].

Medicina, 1995
G, Rey, G, Tate, A, Malbrán
openaire   +1 more source

New approaches to treating chronic obstructive pulmonary disease with Colla corii asini

Animal Models and Experimental Medicine, EarlyView.
Colla corii asini improves chronic obstructive pulmonary disease (COPD) treatment through anti‐inflammatory, antioxidant, immune‐modulatory, and lung‐nourishing effects, addressing current therapeutic challenges via multitarget mechanisms. Abstract Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death and disability ...
Wenchao Zhang, Siman Sun, Xiaoyu Fan, Jiuming He, Qing Li, Hongtao Jin   +5 more
wiley   +1 more source

Discovery of a First‐in‐Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic Activity

Angewandte Chemie, EarlyView.
A covalent allosteric inhibitor M029 was discovered for SHP1, a novel target for immunotherapy. M029 binds to a cryptic Cys remote from the active site, exhibits robust target engagement, and blocks tumor progression by stimulating antitumor immune response.
Zihan Qu, Frederick Nguele Meke, Zheng Zhang, Aaron D. Krabill, Christine S. Muli, Brenson A. Jassim, Jiajun Dong, Quyen D. Nguyen, Yunpeng Bai, Jinyue Li, Yiming Miao, Bardia Asadi, Levi M. Johnson, Jinmin Miao, Darci J. Trader, W. Andy Tao, Zhong‐Yin Zhang   +16 more
wiley   +2 more sources

CD4⁺ T cells stratification unveils a dynamic pathogen landscape in severe pneumonia: a targeted next-generation sequencing-based cohort study. [PDF]

Front Cell Infect Microbiol
Wang S, Yu Y, Lihe C, Sun L, Du N, Minglei Z.   +5 more
europepmc   +1 more source

Correlation analysis on total lymphocyte count and CD4 count of HIV-infected patients

International Journal of Clinical Practice, 2007
F. R. Liu, F. Guo, J. J. Ye, C. F. Xiong, P. L. Zhou, J. G. Yin, L. X. Ye   +6 more
openaire   +1 more source